Welcome to the Neurotech Investing & Partnering Conference

Now in its 14th year, the Neurotech Investing & Partnering Conference (being held May 21-22, 2019 at the Renaissance Waterfront Hotel in Boston, MA) is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients.

The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.


HEAR FROM INFLUENTIAL SPEAKERS:

Eric Schaeffer, PhD
Senior Director of Neuroscience Innovation, Johnson & Johnson Innovation

Pierandrea Muglia, MD
Vice President & Head Neuroscience Discovery Medicine, UCB Pharma

Murali Gopalakrishnan, MBA, PhD
Senior Director & Global Head, Search & Evaluation Neuroscience

Robert Bagdorf, MD, MBA
Vice President, Global Business Development, Pfizer

Nicholas Scarchilli
Director, Business Development, Biogen

Atsushi Hashimoto
Vice President, Business Development, Mitsubishi Tanabe Pharma


MEET INVESTORS AND VCs INCLUDING:



Attendee Demographics


Register Early for Maximum Savings